We are live on ! Find out more
CM

CM Management Portfolio holdings

AUM $120M
1-Year Est. Return 37.12%
This Fund
S&P 500
This Quarter Est. Return
+4.06%
1 Year Est. Return
+37.12%
3 Year Est. Return
+141.34%
5 Year Est. Return
+139.46%
10 Year Est. Return
–
AUM
$134M
AUM Growth
-$4.28M
Cap. Flow
-$3.27M
Cap. Flow %
-2.44%
Top 10 Hldgs %
36.56%
Holding
98
New
12
Increased
28
Reduced
7
Closed
7

Top Buys

1
KMI icon
Kinder Morgan
KMI
+$1.7M
2
OGN icon
Organon & Co
OGN
+$640K
3
GTX icon
Garrett Motion
GTX
+$575K
4
TBPH icon
Theravance Biopharma
TBPH
+$559K
5
VZ icon
Verizon
VZ
+$553K

Top Sells

1
CLDR
Cloudera, Inc.
CLDR
+$6.74M
2
PFE icon
Pfizer
PFE
+$1.96M
3
SD icon
SandRidge Energy
SD
+$1.76M
4
CYTK icon
Cytokinetics
CYTK
+$1.47M
5
BMY icon
Bristol-Myers Squibb
BMY
+$1.34M

Sector Composition

1 Healthcare 38.49%
2 Financials 15.34%
3 Energy 13.23%
4 Materials 7.47%
5 Technology 6.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ET icon
51
Energy Transfer Partners
ET
$69.9B
– –
0
– –
WBA
52
DELISTED
Walgreens Boots Alliance
WBA
$941K 0.7%
20,000
+5,000
+33% +$241K
PAAS icon
53
Pan American Silver
PAAS
$17.5B
$931K 0.69%
40,000
+20,000
+100% +$522K
ELTX icon
54
Elicio Therapeutics
ELTX
$83.3M
$916K 0.68%
9,375
– –
MTG icon
55
MGIC Investment
MTG
$6.24B
$898K 0.67%
60,000
– –
NKTR icon
56
Nektar Therapeutics
NKTR
$2.29B
$898K 0.67%
3,333
– –
CTXS
57
DELISTED
Citrix Systems Inc
CTXS
$859K 0.64%
8,000
– –
USAP
58
DELISTED
Universal Stainless & Alloy
USAP
$799K 0.6%
78,542
– –
SMSI icon
59
Smith Micro Software
SMSI
$14.6M
$774K 0.58%
4,000
– –
TBPH icon
60
Theravance Biopharma
TBPH
$880M
$740K 0.55%
100,000
+50,000
+100% +$559K
DISCK
61
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$728K 0.54%
30,000
– –
FNF icon
62
Fidelity National Financial
FNF
$14.2B
$680K 0.51%
15,600
+5,200
+50% +$231K
ICPT
63
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$668K 0.5%
45,000
– –
ARKOW
64
DELISTED
ARKO Corp Warrant
ARKOW
$654K 0.49%
300,000
+100,000
+50% +$171K
SPPI
65
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$654K 0.49%
300,000
– –
HRTX icon
66
Heron Therapeutics
HRTX
$91.6M
$641K 0.48%
60,000
+10,000
+20% +$122K
FLXN
67
DELISTED
Flexion Therapeutics, Inc.
FLXN
$610K 0.45%
100,000
+25,000
+33% +$156K
GTX icon
68
Garrett Motion
GTX
$5.86B
$590K 0.44%
+80,000
New +$575K
SRCE icon
69
1st Source
SRCE
$2.02B
$567K 0.42%
12,000
– –
SWN
70
DELISTED
Southwestern Energy Company
SWN
$554K 0.41%
+100,000
New +$488K
CBAY
71
DELISTED
Cymabay Therapeutics
CBAY
$548K 0.41%
150,000
– –
VZ icon
72
Verizon
VZ
$187B
$540K 0.4%
+10,000
New +$553K
DIT icon
73
AMCON Distributing
DIT
$66.9M
$521K 0.39%
5,250
+625
+14% +$66.6K
PLPC icon
74
Preformed Line Products
PLPC
$1.59B
$520K 0.39%
8,000
– –
BCEL
75
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$498K 0.37%
80,000
+20,000
+33% +$133K
1 2
3
4

Similar funds

AA
Ahara Advisors Jersey City, New Jersey $120M AUM
CC
Commons Capital Needham, Massachusetts $120M AUM 31.45% 1-Year Est. Return
DG
Dala Group Hoffman Estates, Illinois $120M AUM
ACM
AIHC Capital Management Central $120M AUM
WAG
Windsor Advisory Group Columbus, Ohio $120M AUM 4.29% 1-Year Est. Return
YMRC
Yorktown Management & Research Company Forest, Virginia $120M AUM 52.72% 1-Year Est. Return
IW
Integrated Wealthcare Durham, North Carolina $120M AUM
BCWM
Ball & Co Wealth Management Franklin, Tennessee $120M AUM 21.28% 1-Year Est. Return

CM Management's Q3 2021 Portfolio in Review

As of Q3 2021, CM Management held 98 positions worth $134M, down 3.1% from $138M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

CM Management's Q3 2021 filing shows 12 new, 28 increased, 7 reduced and 7 closed positions. Its largest new stake was Kinder Morgan: 100,000 shares worth $1.67M. The largest sale was Cloudera, Inc., an estimated $6.74M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 37% a quarter earlier, followed by Financials and Energy.

  • CM Management's largest Q3 2021 buy was Kinder Morgan: 100,000 shares worth $1.67M.
  • CM Management added most to Organon & Co in Q3 2021, an estimated $640K increase.
  • CM Management's biggest Q3 2021 reduction was Cytokinetics, cutting an estimated $1.47M.
  • CM Management fully exited Cloudera, Inc. in Q3 2021, selling an estimated $6.74M.
  • CM Management's ten largest holdings make up 37% of its $134M portfolio in Q3 2021.
  • CM Management opened 12 new positions and closed 7 in Q3 2021.
  • CM Management's portfolio value fell 3.1% quarter-over-quarter to $134M.

Based on CM Management's 13F filing for Q3 2021, filed 8 Nov 2021.